Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel-Hashomer, Ramat Gan, affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel (all authors)..
Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel-Hashomer, Ramat Gan, affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel (all authors).
J Minim Invasive Gynecol. 2020 Mar-Apr;27(3):625-632. doi: 10.1016/j.jmig.2019.06.008. Epub 2019 Jun 15.
To describe the management of interstitial pregnancies in a tertiary medical center, identify factors associated with treatment failure, and report subsequent pregnancy outcome.
Retrospective cohort study.
Department of Gynecology in a tertiary medical center.
All women who were admitted to and treated for interstitial pregnancy at our center between 2011 and 2019.
The women were originally assigned to undergo expectant, medical, or surgical treatment. The women's background and clinical data were compared according to initial treatment modality. Nonsurgical (expectant and medical) management outcomes were analyzed to identify risk factors for treatment failure. Subsequent pregnancy outcomes were described separately.
Thirty-seven cases of interstitial pregnancy were identified. There were high rates of pregnancy achieved by in vitro fertilization (45.9%) and a history of ipsilateral salpingectomy (43.2%) among these patients. At presentation, the mean age of the study cohort was 34.76 years, and the median β-human chorionic gonadotropin level was 3853.0, and median gestational age was 7.0, respectively. The nonsurgical management success rate was 70.0%. Uterine rupture occurred during treatment in 5 cases (16.6%). Gestational sac diameter significantly affected treatment failure (p = .03), and a diameter >20 mm was observed in all cases of failed non-surgical treatment. Data on future fertility was available for 21 (58.3%) women: 13 (61.9%) had a subsequent pregnancy, 1 of which was a recurrent interstitial pregnancy. The median interpregnancy interval was 8.1 months, and all but 3 pregnancies reached third trimester and resulted in a live birth, with an overall cesarean delivery rate of 61.5%. None of the subsequent pregnancies were complicated by uterine rupture, and no serious adverse outcomes were noted in any of the subsequent intrauterine pregnancies that reached third trimester.
Successful nonsurgical management of an interstitial pregnancy is feasible, although appropriate selection of cases is advised. A large gestational sac is a risk factor for treatment failure and should prompt surgical intervention. Subsequent pregnancies can generally be considered safe and with a favorable outcome.
描述在一家三级医学中心对间质部妊娠的管理,确定与治疗失败相关的因素,并报告后续妊娠结局。
回顾性队列研究。
一家三级医学中心的妇科。
2011 年至 2019 年在我院接受间质部妊娠治疗的所有女性。
这些女性最初被分配接受期待、药物或手术治疗。根据初始治疗方式比较了女性的背景和临床数据。分析非手术(期待和药物)管理结果,以确定治疗失败的风险因素。单独描述了后续妊娠结局。
共确定 37 例间质部妊娠。这些患者中,体外受精妊娠率高(45.9%),同侧输卵管切除术史(43.2%)高。就诊时,研究队列的平均年龄为 34.76 岁,β-人绒毛膜促性腺激素中位数为 3853.0,中位妊娠年龄为 7.0。非手术治疗成功率为 70.0%。5 例(16.6%)在治疗过程中发生子宫破裂。妊娠囊直径显著影响治疗失败(p=0.03),所有非手术治疗失败的病例妊娠囊直径均>20mm。21 例(58.3%)有后续生育数据:13 例(61.9%)再次妊娠,其中 1 例为复发性间质部妊娠。两次妊娠的中位间隔时间为 8.1 个月,除 3 例外,所有妊娠均进入晚期,均活产,剖宫产率总体为 61.5%。无后续妊娠发生子宫破裂,且无严重不良结局。
间质部妊娠的非手术成功治疗是可行的,但应慎重选择病例。妊娠囊较大是治疗失败的危险因素,应及时进行手术干预。一般来说,后续妊娠通常是安全的,结局良好。